GUTS

Fractyl Health, Inc. (GUTS) Economic Moat Analysis (2026)

Invetso Score: 1.4/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Intangible Assets

Score: 2.0 (Weak)

GUTS does not appear to possess meaningful proprietary brands, patents, or regulated intellectual property that would sustain pricing power versus peers, so intangible assets are not a durable moat driver.

The provided profitability metrics show deeply negative ROIC and ROCE, which is consistent with weak monetization of any intangible assets relative to peers.

No evidence in the supplied data indicates customer preference or regulatory exclusivity that would make competitors materially dependent on GUTS, unlike stronger peer moats built on protected IP or entrenched brands.

With no visible asset-based differentiation that improves retention or margins over a 5–10 year horizon, intangible assets remain easily replicable versus peers.

Switching Costs

Score:

The available metrics do not show recurring-contract economics, embedded workflows, or integration depth that would make customers costly to replace, so switching costs appear minimal versus peers.

Negative ROIC and ROCE suggest the business is not extracting durable retention economics from its customer base, which weakens evidence of lock-in relative to stronger peers.

There is no supplied evidence of data migration friction, compliance dependency, or operational disruption that would force customers to stay, unlike businesses with high switching barriers.

Absent contractual or technical lock-in, customers can likely compare alternatives on price and service, which limits long-term pricing power and retention.

Network Effects

Score:

The provided information does not indicate a user, data, or ecosystem flywheel that would make the platform more valuable as participation rises, so network effects are not evident versus peers.

Negative profitability metrics do not support the presence of scale-driven self-reinforcement that typically accompanies strong network effects.

No evidence suggests that customers, suppliers, or third parties are dependent on GUTS as a core platform, unlike peer businesses with clear two-sided network advantages.

Without observable cross-user value creation or ecosystem lock-in, network effects do not materially support durability of competitive advantage.

Cost Advantage

Score:

The negative ROIC and ROCE imply that GUTS is not converting capital into returns efficiently enough to indicate a structural cost advantage versus peers.

The supplied data show no sign of superior unit economics, asset productivity, or scale purchasing power that would allow lower prices while preserving margins.

With no evidence of proprietary process efficiency or lower operating cost structure, competitors likely can match or undercut pricing more easily.

Because the business is not demonstrating durable margin resilience, cost advantage does not appear to be a meaningful moat source over a 5–10 year horizon.

Efficient Scale

Score:

The available metrics do not show evidence of a concentrated market structure or natural monopoly economics that would let GUTS serve demand more efficiently than peers.

Negative returns on capital suggest scale is not currently translating into operating leverage or barrier-like economics.

No supplied data indicate that the market is too small for multiple efficient competitors, which is the key condition for efficient scale to protect margins.

Without clear capacity constraints, regulatory barriers, or dominant infrastructure ownership, efficient scale does not appear to constrain peer entry or expansion.

Overall Score

Score:

GUTS screens as a weak-moat business versus peers because the supplied data show deeply negative capital returns and no evidence of durable intangible assets, switching costs, network effects, cost advantage, or efficient scale; as a result, pricing power and retention appear easy to contest over the next 5–10 years.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Fractyl Health, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →